Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome

Circ J. 2008 Oct;72(10):1707-8. doi: 10.1253/circj.cj-08-0401. Epub 2008 Sep 2.

Abstract

Background: A lower maintenance dose of clopidogrel may be appropriate in Japanese patients because the maintenance dose of ticlopidine is lower in Japan than that used in the United States.

Methods and results: A total of 126 patients with 153 lesions who consented to take 50-mg clopidogrel to prevent stent thrombosis were enrolled. There was 1 case of early stent thrombosis (0.65%). Side-effects of clopidogrel occurred in 5 patients (4.0%).

Conclusion: This preliminary study shows that 50 mg clopidogrel may be acceptable in Japanese patients.

MeSH terms

  • Aged
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Disease / surgery*
  • Coronary Restenosis / prevention & control*
  • Coronary Thrombosis / surgery
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Safety
  • Stents*
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin